Pharmaceutical companies race to develop monoclonal antibody treatment for COVID-19 – CBS News

As the coronavirus pandemic rages on, the makers of the influenza vaccine are planning to deliver a record 200 million dosages to the U.S. to prevent Americans from getting knocked by the influenza next season. Now, … [+1349 chars]